|
|
|
|
LEADER |
03116nmm a2200301 u 4500 |
001 |
EB000622569 |
003 |
EBX01000000000000000475651 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
140122 ||| eng |
020 |
|
|
|a 9781461340423
|
100 |
1 |
|
|a Iversen, Leslie
|e [editor]
|
245 |
0 |
0 |
|a Handbook of Psychopharmacology
|h Elektronische Ressource
|b Volume 10: Neoroleptics and Schizophrenia
|c edited by Leslie Iversen
|
250 |
|
|
|a 1st ed. 1978
|
260 |
|
|
|a New York, NY
|b Springer US
|c 1978, 1978
|
300 |
|
|
|a XII, 250 p
|b online resource
|
505 |
0 |
|
|a 2. Survey of Neurotransmitter Theories -- 3. General Principles Underlying Neurotransmitter Theories in Psychiatry -- 4. Attention in Schizophrenia and Its Pharmacology -- 5. References
|
505 |
0 |
|
|a 5. Cost of Medication and Dispensing -- 6. Antipsychotic Drugs and Somatic Therapies -- 7. Drug Combinations -- 8. Drug, Psychological, and Social Treatments -- 9. New Antipsychotic Drugs -- 10. References -- 5 Tardive Dyskinesia and Related Neurologic Disorders -- 1. Historical Background -- 2. Clinical Findings -- 3. Predisposing Factors -- 4. Drug Effects -- 5. Severity and Combinations of Symptoms -- 6. Disability and Complications -- 7. Differential Diagnosis -- 8. Pathophysiology -- 9. Neuropharmacology -- 11. Concluding Remarks -- 12. References -- 6 Reserpine: Basic and Clinical Pharmacology -- 1. Introduction -- 2. Source, History, and Analogs -- 3. Distribution and Metabolism -- 4. Pharmacological Effects in Laboratory Animals -- 5. Clinical Pharmacology -- 6. Biochemical Mechanism of Action -- 7. Interaction of Reserpine with Other Centrally Acting Drugs -- 8. The Reserpine Receptor -- 9. References -- 7 Neurotransmitter Theories of Schizophrenia -- 1. Introduction --
|
505 |
0 |
|
|a 1 Structure-Activity Relationships of the Butyrophenones and Diphenylbutylpiperidines -- 1. Introduction -- 2. Structure-Activity Relationships -- 3. Pharmacology -- 4. Conclusion -- 5. References -- 2 Biochemical Actions of Neuroleptic Drugs: Focus on the Dopamine Receptor -- 1. Introduction -- 2. Early Biochemical Studies -- 3. Dopamine Metabolism and Neuroleptics -- 4. The Dopamine-Sensitive Adenylate Cyclase -- 5. Labeling the Dopamine Receptor -- 6. References -- 3 Behavioral Actions of Neuroleptics -- 1. Introduction -- 2. Effect on Feeding and Drinking -- 3. Locomotor Activity and Catalepsy -- 4. Antiamphetamine Action -- 5. Avoidance Behavior -- 6. Brain Self-Stimulation -- 7. Aggression -- 8. Narcotic-Withdrawal Syndrome -- 9. Conclusions -- 10. References -- 4 Neuroleptics: Clinical Use in Psychiatry -- 1. Introduction -- 2. The Methodology of Drug Studies -- 3. Efficacy of Antipsychotic Drugs -- 4. Maintenance Treatment with Antipsychotic Medication --
|
653 |
|
|
|a Behavioral Sciences and Psychology
|
653 |
|
|
|a Psychiatry
|
653 |
|
|
|a Psychology
|
653 |
|
|
|a Pharmacology
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
028 |
5 |
0 |
|a 10.1007/978-1-4613-4042-3
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4613-4042-3?nosfx=y
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 615
|